Annals of Emergency Medicine
Volume 44, Issue 1 , Pages 3-11 , July 2004

Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study

Received 16 July 2003 ,Revised 31 December 2003 ,Accepted 6 January 2004.

References 

  1. Go AS, Hylek EM, Phillips KA, et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prophylaxis: the Anticoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375
  2. Atrial Fibrillation Investigators . Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449–1457
  3. Hart RG, Benavente O, McBride R, et al.  Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131:492–501
  4. Bungard TJ, Ghali WA, Teo KK, et al.  Why do patients with atrial fibrillation not receive warfarin?. Arch Intern Med. 2000;160:41–46
  5. Fatovich DM. Emergency medicine: recent developments. BMJ. 2002;324:958–962
  6. Magnusson G. The hospital emergency department as the primary source of medical care. Scand J Soc Med. 1980;8:149–156
  7. Brown EM, Goel V. Factors related to emergency department use: results from the Ontario Heath Survey 1990. Ann Emerg Med. 1994;24:1083–1091
  8. Martı́n A, Laguna P, Del Arco C, et al. , on behalf of the GEFAUR investigators   The Spanish Atrial Fibrillation in Emergency Medicine Study Group (GEFAUR): background, aims and design of a prospective multicenter study of atrial fibrillation in hospital emergency departments. Emergencias. 2001;13:235–240
  9. Laupacis A, Albers G, Dalen J, et al.  Antithrombotic therapy in atrial fibrillation. Chest. 1998;114:579S–589S
  10. Villar F, Banegas JR, De Mata J, et al.  Situation of cardiovascular diseases in Spain. Rev Clin Esp. 2003;203(Suppl 1):2–5
  11. American Heart Association Committee on Electrocardiography . Recommendations for standarization of leads and specifications for instruments in electrocardiography and vectocardiography. Circulation. 1967;35:583–602
  12. Levy S, Novella P, Ricard P, et al.  Paroxismal atrial fibrillation: a need for classification. J Cardiovasc Electrophysiol. 1995;6:69–74
  13. Benjamin EJ, Levy D, Vaziri SM, et al.  Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271:840–844
  14. Fuster V, Ryden LE, Asinger RW, et al.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Circulation. 2001;104:2118–2150
  15. Katz S, Ford AB, Moskowitz RW, et al.  Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–919
  16. Martı́n A, Merino JL, Del Arco C, et al.  Consensus document for the management of patients with atrial fibrillation in hospital emergency departments. Rev Esp Cardiol. 2003;56:801–816
  17. Thomson R, McElroy H, Sudlow M. Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment. BMJ. 1998;316:509–513
  18. Scott PA, Pancioli AM, Davis LA, et al.  Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke. 2002;33:2664–2669
  19. Balanzó X, Pujol R. A multicentric study of emergencies in basic general hospitals in Catalonia. Intercomarcal Internal Medicine Group. Med Clin (Barc). 1989;92:86–90
  20. Munschauer FE, Priore RL, Hens M, et al.  Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary-care hospitals. Stroke. 1997;28:72–76
  21. Sudlow M, Thomson R, Thwaites B, et al.  Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998;352:1167–1171
  22. Gurwitz JH, Monette J, Rochon PA, et al.  Atrial fibrillation and stroke prophylaxis with warfarin in the long-term care setting. Arch Intern Med. 1997;157:978–984
  23. Albers GW, Dalen JE, Laupacis A, et al.  Antithrombotic therapy in atrial fibrillation. Chest. 2001;119:194S–206S
  24. Levine MN, Raskob G, Landefeld S, et al.  Hemorrhagic complications of anticoagulant treatment. Chest. 2001;119:108S–121S
  25. Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice?. Arch Intern Med. 1994;154:1945–1953
  26. Evans A, Kalra L. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?. Arch Intern Med. 2001;161:1443–1447
  27. Rodgers H, Sudlow M, Dobson R, et al.  Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views. Br J Gen Pract. 1997;47:309–310
  28. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897–902
  29. Fihn SD, Callahan CM, Martin DC, et al. , for the National Consortium of Anticoagulation   The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med. 1996;124:970–979

☆ The participating investigators are listed in the Appendix.

☆☆ Author contributions: AM, CG, PL, and PG conceived and designed the study. AM supervised the conduct of the study and the data collection and was responsible for the design and codification of the data collection sheet. CG provided statistical advice on study design and the data analysis. CG, AM, and PL drafted the manuscript and take responsibility for the paper as a whole.

★ Presented in part as an abstract at the XXIV Congress of the European Society of Cardiology, Berlin, Germany, September 1-4, 2002.

★★ Supported by an unintentional grant of 3M-Spain, which was not involved in any other way in the development of this study and had no influence in the contents of the article.

☆☆☆ Reprints not available from the authors.

PII: S0196-0644(04)00058-7

doi: 10.1016/j.annemergmed.2004.01.010

Annals of Emergency Medicine
Volume 44, Issue 1 , Pages 3-11 , July 2004

Article Tools

* Image Usage & Resolution